Drug search by name

Lanreotide and Hepatic impairment

Result of checking the interaction of drug Lanreotide and disease Hepatic impairment for safety when used together.

Check result:

Lanreotide <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

In clinical trials, a reduced clearance of lanreotide was observed in subjects with moderate to severe hepatic impairment. Patients with moderate to severe hepatic impairment should begin treatment with lanreotide 60 mg. Caution should be exercised when using this agent in patients with moderate or severe hepatic impairment for an extended dosing interval.

Lanreotide

Generic Name: lanreotide

Brand Name: Somatuline Depot

Synonyms: n.a.

What is Lanreotide?